## MDT: Medtronic plc - XLV: Healthcare

### Executive Summary

No thesis match: PEG 3.64 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($97.22)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. The Truth About Medtronic plc: Is This ‘Boring’ Stock Actually a Silent Flex?**
- Source: AD HOC NEWS | 20260105T080832 | Somewhat-Bullish | Relevance: 100%
- Medtronic plc is presented as a medical technology giant that, while not a "meme stock," is a significant player in healthcare. The article explores whether this "boring" stock is a valuable long-term investment, examining its business, market perception, and risks. It concludes that Medtronic is a stable, dividend-paying company suited for core portfolios rather than speculative, high-volatility trading.

**2. Commonwealth Equity Services LLC Reduces Stock Holdings in Medtronic PLC $MDT**
- Source: MarketBeat | 20260106T091834 | Neutral | Relevance: 100%
- Commonwealth Equity Services LLC reduced its stake in Medtronic PLC by 14.6% in the third quarter of 2025, selling 133,774 shares and retaining 783,148 shares valued at approximately $74.59 million. Despite this, Medtronic reported strong Q3 earnings, beating analyst expectations with $1.36 EPS and $8.96 billion in revenue, and issued optimistic FY2026 guidance. The company also declared a quarterly dividend of $0.71 and maintains a "Moderate Buy" consensus rating from analysts.

**3. Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly**
- Source: Simply Wall Street | 20260105T222151 | Somewhat-Bullish | Relevance: 100%
- Medtronic plc (NYSE:MDT) manages its debt responsibly, as indicated by its moderate net debt to EBITDA ratio of 2.2 and strong interest cover of 28.3 times. The company's ability to convert 77% of its EBIT into free cash flow further strengthens its financial position, showing it can reduce debt effectively. Despite having US$29.0 billion in debt, Medtronic's US$8.33 billion in cash results in a net debt of US$20.7 billion, which is manageable given its large market capitalization of US$123.1 billion.

**4. D.A. Davidson & CO. Has $20.33 Million Holdings in Medtronic PLC $MDT**
- Source: MarketBeat | 20260105T141625 | Bullish | Relevance: 100%
- D.A. Davidson & CO. has lowered its stake in Medtronic PLC (NYSE:MDT) by 9.9% in Q3, now holding 213,482 shares valued at $20.33 million. Medtronic exceeded Q3 earnings estimates with $1.36 EPS and $8.96 billion in revenue, forecasting FY26 EPS between $5.62 and $5.66. The company also announced a quarterly dividend of $0.71, translating to an annualized yield of approximately 3.0%.

**5. Asset Management One Co. Ltd. Has $56.11 Million Stake in Medtronic PLC $MDT**
- Source: MarketBeat | 20260104T095124 | Bullish | Relevance: 100%
- Asset Management One Co. Ltd. increased its holdings in Medtronic PLC (NYSE:MDT) by 2.4% in the third quarter, bringing its total stake to 589,186 shares valued at $56.11 million. Medtronic recently outperformed Q3 earnings estimates with an EPS of $1.36 and revenue of $8.96 billion, and announced a quarterly dividend of $0.71. The company holds a consensus "Moderate Buy" rating from analysts with an average target price of $109.94.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2026-01-06 | William Blair | $0 | $0 | 0% |
| 2025-12-18 | Truist Securiti | $107 | $110 | -3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2026-01-06 | William Blair | up | Outperform |
| 2025-12-18 | Truist Securiti | main | Hold |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 6 ($0.53M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 43.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 9.9% (+0.1%)
- Blackrock Inc.: 9.3% (-2.4%)
- JPMORGAN CHASE & CO: 8.1% (+197.7%)
- State Street Corpora: 4.7% (+1.1%)
- Capital Research Glo: 2.4% (-15.6%)

### Key Risks

1. Valuation stretched: PEG 3.6x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_10 improving +3.9% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.64 signals overvaluation risk, limited margin of safety. Forward P/E 16.4x stretched relative to 8% growth. Balance sheet: strong liquidity (2.4x). Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $128.7B |
| Beta | 0.73 |
| 52W Range | $79.55 - $106.33 |
| Short Interest | 1.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.64 |
| Forward P/E | 16.4 |
| Current P/E | 17.8 |
| YoY Growth | 8.2% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -0.8% to 3.1% (+3.9% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (3.0-6.0%), cross-sectional ranking at 72nd percentile. MRS_5 at 2.4% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 60. OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 3.08% (CS: 72) | Strong |
| RSI_14 | 59.9 | Neutral |
| MACD Histogram | -0.01 | Bearish |
| vs SMA20 | 1.022x | Above |
| vs SMA50 | 1.029x | Above |
| vs SMA200 | 1.098x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $100.34
- **Stop Loss:** $97.22 (3.1% risk)
- **Target:** $103.46 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 423
- **Position Value:** $42,443.82
- **Portfolio %:** 42.44%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_ON (MEDIUM) | 1.10x |
| L2 Sector | TREND (Zone A) | 1.20x |

*RISK_ON regime with strong participation and low volatility. VIX at 14.75 (6th percentile) with breadth at 63.5% signals healthy risk appetite. Fed dovish expectations and AI/semiconductor momentum are primary drivers, though elevated put/call ratio suggests smart money hedging. Focus on quality growth with awareness of potential complacency.*

### Earnings

**Next:** 2026-02-17 (Est: $1.34)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $1.31 | $1.36 | +3.5% |
| 2025Q3 | $1.23 | $1.26 | +2.5% |
| 2025Q2 | $1.58 | $1.62 | +2.7% |
| 2025Q1 | $1.36 | $1.39 | +2.2% |

---
*RULE-based L3 | 2026-01-07 08:25 | MRS_10*